Wasdell acquires specialist packaging supplier
The acquisition will strengthen Wasdell’s capabilities and product offerings, including 100% recyclable and biodegradable options, in the medical device sector.
The Wasdell Group, a pharmaceutical outsourcing partner, has acquired Planned Packaging Limited & Planned Packaging Films Limited (PPF), a specialist packaging supplier to the medical device and pharmaceutical sectors.
The acquisition will strengthen and expand Wasdell’s capability to be a fully integrated supplier to its growing client base within the life science and medical device sector.
Planned Packaging brings over 40 years’ experience supplying leading global medical device manufacturers and pharmaceutical companies in the UK, Europe and the Americas. The products supplied comply with ISO 11607/Medical Device Reporting (MDR ) requirements and are manufactured in an ISO 8 cleanroom environment.
Vincent Dunne, Wasdell Group CEO commented: “The acquisition of PPF allows the Wasdell Group to vertically integrate into a key commodity area, safeguarding supplies but also expanding our capabilities and product and service offerings.”
The product range includes pre-made easy-peel pouches, high barrier foil films and semi-rigid materials for processing through thermoforming lines. There is also the ability to custom print on a wide range of materials as well as advise customers on the most suitable packaging solution.
As demand for more sustainable materials increases, Planned Packaging is leading the way by introducing new 100% recyclable and biodegradable options.
Martin Tedham, Chairman of the Wasdell Group added: “Planned Packaging is a perfect fit due to its synergies within the existing Wasdell operations, a shared customer base, operating within the same sectors as well as a growing demand for the assembly and packaging of medical devices seen within Wasdell’s outsourced packaging services.
“Customers will benefit from expanded services and competitive prices and the integrations of Planned Packaging into our current operations will be a beneficial and advantageous one for all involved. We are pleased to welcome the Planned Packaging team to the Wasdell family and look forward to working alongside them.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance